ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.
Pediatric Highly Intensive Care Unit, Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy These authors contributed equally.
Susanna
S
Esposito
World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy These authors contributed equally.
Lia
L
D'Ambrosio
Section of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy These authors contributed equally.
Marina
M
Tadolini
Desmond Tutu Tuberculosis Centre, Dept of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
H Simon
HS
Schaaf
Dept of Pneumology, Hospital General de Gran Canaria, Las Palmas, Spain.
Josè
J
Caminero Luna
Marie Bashir Institute for Infectious Diseases and Biosecurity, and Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, Australia.
Ben
B
Marais
World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
Rosella
R
Centis
World Health Organization Regional Office for Europe, Copenhagen, Denmark.
Masoud
M
Dara
Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV co-infection and TB elimination, University of Brescia, Brescia, Italy.
Alberto
A
Matteelli
Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, Italy.
Francesco
F
Blasi
World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy giovannibattista.migliori@fsm.it.
Giovanni Battista
GB
Migliori
D000995:Antitubercular Agents / Q000008:administration & dosage*; D002648:Child; D057176:Compassionate Use Trials; D004196:Disease Outbreaks; D005060:Europe; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007558:Italy; D008297:Male; D009593:Nitroimidazoles / Q000008:administration & dosage*; D010080:Oxazoles / Q000008:administration & dosage*; D016730:Program Development; D012955:Societies, Medical; D016896:Treatment Outcome; D014944:World Health Organization
D000995:Antitubercular Agents; D009593:Nitroimidazoles; C516022:OPC-67683; D010080:Oxazoles